BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31099111)

  • 1. Interleukin-37 is highly expressed in regulatory T cells of melanoma patients and enhanced by melanoma cell secretome.
    Osborne DG; Domenico J; Luo Y; Reid AL; Amato C; Zhai Z; Gao D; Ziman M; Dinarello CA; Robinson WA; Fujita M
    Mol Carcinog; 2019 Sep; 58(9):1670-1679. PubMed ID: 31099111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of ICOS on human melanoma-infiltrating CD4+CD25highFoxp3+ T regulatory cells: implications and impact on tumor-mediated immune suppression.
    Strauss L; Bergmann C; Szczepanski MJ; Lang S; Kirkwood JM; Whiteside TL
    J Immunol; 2008 Mar; 180(5):2967-80. PubMed ID: 18292519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-200a expression in CD4+ T cells correlates with the expression of Th17/Treg cells and relevant cytokines in psoriasis vulgaris: A case control study.
    Wang XY; Chen XY; Li J; Zhang HY; Liu J; Sun LD
    Biomed Pharmacother; 2017 Sep; 93():1158-1164. PubMed ID: 28738533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triptolide downregulates Treg cells and the level of IL-10, TGF-β, and VEGF in melanoma-bearing mice.
    Liu B; Zhang H; Li J; Lu C; Chen G; Zhang G; Lu A; He X
    Planta Med; 2013 Oct; 79(15):1401-7. PubMed ID: 23975869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of IL-37 contributes to the immunosuppressive property of human CD4+CD25+ regulatory T cells.
    Shuai X; Wei-min L; Tong YL; Dong N; Sheng ZY; Yao YM
    Sci Rep; 2015 Sep; 5():14478. PubMed ID: 26411375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel role of IL-37 to enhance the anti-inflammatory response of regulatory T cells in patients with peripheral atherosclerosis.
    Lotfy H; Moaaz M; Moaaz M
    Vascular; 2020 Oct; 28(5):629-642. PubMed ID: 32366176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased Suppression and Increased Phosphorylated STAT3 in Regulatory T Cells are Associated with Benefit from Adjuvant PD-1 Blockade in Resected Metastatic Melanoma.
    Woods DM; Ramakrishnan R; Laino AS; Berglund A; Walton K; Betts BC; Weber JS
    Clin Cancer Res; 2018 Dec; 24(24):6236-6247. PubMed ID: 30131384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanoma induces immunosuppression by up-regulating FOXP3(+) regulatory T cells.
    Baumgartner J; Wilson C; Palmer B; Richter D; Banerjee A; McCarter M
    J Surg Res; 2007 Jul; 141(1):72-7. PubMed ID: 17574040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoid hormone differentially modulates the in vitro expansion and cytokine profile of thymic and splenic Treg cells.
    Pap R; Ugor E; Litvai T; Prenek L; Najbauer J; Németh P; Berki T
    Immunobiology; 2019 Mar; 224(2):285-295. PubMed ID: 30612787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice.
    Kao JY; Zhang M; Miller MJ; Mills JC; Wang B; Liu M; Eaton KA; Zou W; Berndt BE; Cole TS; Takeuchi T; Owyang SY; Luther J
    Gastroenterology; 2010 Mar; 138(3):1046-54. PubMed ID: 19931266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptive NK Cells Resist Regulatory T-cell Suppression Driven by IL37.
    Sarhan D; Hippen KL; Lemire A; Hying S; Luo X; Lenvik T; Curtsinger J; Davis Z; Zhang B; Cooley S; Cichocki F; Blazar BR; Miller JS
    Cancer Immunol Res; 2018 Jul; 6(7):766-775. PubMed ID: 29784636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The regulation of regulation: interleukin-10 increases CD4
    He L; Zhou S; Qi Q; Chi Y; Zhu J; Xu Z; Wang X; Hoellwarth J; Liu F; Chen X; Su C
    Immunology; 2018 Jan; 153(1):84-96. PubMed ID: 28799262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid suppression of cytokine transcription in human CD4+CD25 T cells by CD4+Foxp3+ regulatory T cells: independence of IL-2 consumption, TGF-beta, and various inhibitors of TCR signaling.
    Oberle N; Eberhardt N; Falk CS; Krammer PH; Suri-Payer E
    J Immunol; 2007 Sep; 179(6):3578-87. PubMed ID: 17785792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of cytokines and T-bet, GATA3, ROR-γt, and FOXP3 transcription factors of T cell subsets in the natural clinical progression of Type 1 Diabetes.
    Ozgur BA; Cinar SA; Coskunpinar E; Yilmaz A; Altunkanat D; Deniz G; Gurol AO; Yilmaz MT
    Immunol Res; 2023 Jun; 71(3):451-462. PubMed ID: 36595206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
    Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory T cells regulate the distribution of natural killer T cells through CD39 signal transduction in asthma.
    Lu Y; Li Y; Zhou W; Ding B; Yu Q
    Hum Cell; 2019 Apr; 32(2):141-149. PubMed ID: 30539423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease.
    Eastaff-Leung N; Mabarrack N; Barbour A; Cummins A; Barry S
    J Clin Immunol; 2010 Jan; 30(1):80-9. PubMed ID: 19936899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting STAT3 Abrogates Tim-3 Upregulation of Adaptive Resistance to PD-1 Blockade on Regulatory T Cells of Melanoma.
    Huang L; Xu Y; Fang J; Liu W; Chen J; Liu Z; Xu Q
    Front Immunol; 2021; 12():654749. PubMed ID: 33936081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overrepresentation of highly functional T regulatory cells in patients with nonfunctioning pituitary adenoma.
    Han S; Ma E; Jiang W; Lu Y; Sun X; Feng S
    Hum Immunol; 2020 Jun; 81(6):314-319. PubMed ID: 32279926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Foxp3 expression in melanoma cells as a possible mechanism of resistance to immune destruction.
    Niu J; Jiang C; Li C; Liu L; Li K; Jian Z; Gao T
    Cancer Immunol Immunother; 2011 Aug; 60(8):1109-18. PubMed ID: 21547596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.